TNKase (T-N-Kase, tenecteplase), a new "third generation" thrombolytic for heart attacks
December 2001
Hoffmann-La Roche is now introducing TNKase (T-N-Kase, tenecteplase), a new "third generation" thrombolytic for heart attacks.
TNKase and the other "third generation" med Retavase (reteplase) are faster and easier to give than older thrombolytics.
TNKase is made by substituting three amino acids of the thrombolytic Activase (alteplase, tPA).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote